Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial
Heather A. Wakelee, Suzanne E. Dahlberg, Steven M. Keller, William J. Tester, David R. Gandara, Stephen L. Graziano, Alex A. Adjei, Natasha B. Leighl, Seena C. Aisner, Jan M. Rothman, Jyoti D. Patel, Mark D. Sborov, Sean R. McDermott, Roman Perez-Soler, Anne M. Traynor, Charles Butts, Tracey Evans, Atif Shafqat, Andrew E. Chapman, Samer S. KasbariLeora Horn, Suresh S. Ramalingam, Joan H. Schiller
Dive into the research topics of 'Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial'. Together they form a unique fingerprint.